Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Novartis
Novartis
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
Genentech, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OncoC4, Inc.
Pfizer
USWM, LLC (dba US WorldMeds)
Seagen Inc.
Pfizer
Sotio Biotech Inc.
National Cancer Institute (NCI)
Pfizer
Dana-Farber Cancer Institute
ViroMissile, Inc.
Erasca, Inc.
Pfizer
Tizona Therapeutics, Inc
St. Jude Children's Research Hospital
MacroGenics
Hefei TG ImmunoPharma Co., Ltd.
City of Hope Medical Center
Conjupro Biotherapeutics, Inc.
AgonOx, Inc.
Innate Pharma
Novartis
City of Hope Medical Center
Amgen
Kezar Life Sciences, Inc.
Degron Therapeutics Co.
University Health Network, Toronto
NeoTX Therapeutics Ltd.
AccSalus Biosciences, Inc.
Abramson Cancer Center at Penn Medicine
West China Hospital
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Seattle Children's Hospital
Bolt Biotherapeutics, Inc.
AstraZeneca
Tesaro, Inc.
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
MacroGenics
Sichuan Baili Pharmaceutical Co., Ltd.
Ikena Oncology
Chiome Bioscience Inc.
Pfizer
UNC Lineberger Comprehensive Cancer Center